Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-05

Clinical Trial Update: The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps [Phase 4]

View source ↗

Summary

Phase 4 trial update on Combizym and Bifidobacteri to prevent recurrence of colon polyps.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bifidobacteri
  • Combizym

Snippet

Sponsor: RenJi Hospital | Conditions: Combizym, Bifidobacteri | Phase 4 | Status: UNKNOWN